USPatentGranted
B2

Protein and production process and use thereof

Granted 23 Jul 2013 · 2 office actions

Current assignee: TEIJIN PHARMA LIMITED · originally Teijin Limited

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Kei Yamana, Eiji Ochiai, Yoshimasa Takahashi, Yoshiaki Azuma +2 · Examiner: Christine J Saoud · AU 1646 · TC 1600

Life of the patent

13 dated events
⤢ drag to zoom20042006200820102012201420162018202020222024ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Abstract

[PROBLEMS] To provide a polypeptide having a novel structure and showing an activity of inhibiting angiogenesis or an activity of inhibiting osteoclastogenesis, and to provide a recombinant protein by constructing a method of purifying the above protein. To provide an ingredient useful in designing remedies for tendinitis, rheumatoid arthritis, arthritis deformans, malignant tumor, etc. [MEANS FOR SOLVING PROBLEMS] A novel soluble polypeptide protein.

Claims

9 · 3 independent · depth 6
123456789
9 granted claims

Classifications

12 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C12N5/00
  • C12P21/06
  • C07H21/04
  • C12P21/04
  • C12N15/00
USPC · US Patent Classification
435/69.1435/320.1435/69.7536/23.4435/325536/23.5435/70.1

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom200520062007200820092010201120122013USPTOApplicantRestriction requirementResponse after non-finalExaminer-initiated interview
USPTOApplicanthover for detail · click to open
Pendency
8.8 y
3,197 days filing → grant
Office actions
1
after a restriction
Responses
1
no RCE
Interviews
5
examiner interview summaries
Examiner
Christine J Saoud
art unit 1646 · TC 1600
Citations: 18 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Priority chain

1 priority documents
›Priority documents — 1
TypeDocumentDate
related publicationUS 20090313711 A117 Dec 2009

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock